EnteroMedics Announces EMPOWER Trial Hypertension Data Presented at the American Heart Association’s 2012 Scientific Sessions

[at noodls] – ST. PAUL, MN — (Marketwire) — 11/07/12 — EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal … more

View todays social media effects on ETRM

View the latest stocks trending across Twitter. Click to view dashboard